Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma (PNOC008)

This is a 2 strata pilot trial within the Pacific Pediatric Neuro-Oncology Consortium (PNOC). The study will use a new treatment approach based on each patient’s tumor gene expression, whole-exome sequencing (WES), targeted panel profile (UCSF 500 gene panel), and RNA-Seq. The current study will test the efficacy of such an approach in children with High-grade gliomas HGG.

NCT: NCT03739372

Locations: Children’s Hospitals and Clinics of Minneapolis, University of Minnesota

Link: https://clinicaltrials.gov/ct2/show/NCT03739372?recrs=ad&cond=Astrocytoma&locn=University+of+Minnesota&cntry=US&draw=2&rank=2